Emerging Viral Diseases: Why We Need to Worry about Bats, Camels, and Airplanes

Viral Pathogenesis: From Basics to Systems Biology: Third Edition

Volumn , Issue , 2016, Pages 215-231

  Le Duc, James W ^a   Nathanson, Neal ^b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chikungunya; Dead end hosts; Ebol; Emerging virus diseases; HIV; Identifying new viruses; Mechanisms of emergence; Re emerging virusdiseases; Sin Nombre virus; SIV; Zoonotic infections

Indexed keywords

EID: 84967214978     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-800964-2.00016-1     Document Type: Chapter

References (54)

1. Eaton BT, Broder CC, Middleton D, Wang L-F. Hendra and Nipah viruses: different and dangerous. Nature Reviews Microbiology 2006, 4: 23-35.
2. Fenner F. Biological control as exemplified by smallpox eradication and myxomatosis. Proceedings of the Royal Society of London, Part B Biological Sciences, 1983, 218: 259-285.
3. Fredericks DN, Relman DA. Sequence-Based Identification of Microbial Pathogens: a Reconsideration of Koch's Postulates. Clinical Microbiology Reviews 1996, 9: 18-33.
4. Howard CR, Fletcher NF. Emerging virus diseases: can we ever expect the unexpected? Emerging Microbes and Infection. 2012, 1, e46 doi. 10.1038/emi.2012.47.
5. Hayes EB, Komar N, Nasci RS, Montgomery SP, O'Leary DR, Campbell GL. Epidemiology and transmission dynamics of West Nile virus disease. Emerging Infectious Diseases 2005, 11: 1167-1173.
6. Lederberg J, Shope RE, Oaks Jr, SC, editors. Emerging Infections. National Academy Press, 1992, Washington, DC.
7. Parrish CR. The emergence and evolution of canine parvovirus - an example of recent host range mutation. Semin Virol 1994, 5: 121-132.
8. Weiss RA, McMichael AJ. Social and environmental risk factors in the emergence of infectious diseases. Nature Medicine Supplement 2004, 10: S70-S76.
9. Wilson MR, Peters DJ. Diseases of the central nervous system caused by lymphocytic choriomeningitis virus and other arenaviruses. Chapter 33, in AC Tselis and J Booss, editors, Handbook of Clinical Neurology, Elsevier, New York, 2014.
10. Abdel-Moneim AS. Middle East respiratory syndrome coronavirus (MERS-CoV) evidence and speculation. Archives of Virology 2014, 159: 1575-1584.
11. Di Giulio DB, Eckburg PB. Human monkeypox: an emerging zoonosis. Lancet Infectious Diseases, 2004, 4: 15-25.
12. Elliott LH, Ksiazek TG, Rollin PE, Spiropoulou CF, Morzunov S, Monroe M, Goldsmith CS, Humphrey CD, Zaki SR, Krebs JW, et al. Isolation of the causative agent of hantavirus pulmonary syndrome. Am J Tropical Medicine and Hygiene 1994, 51: 102-108.
13. Enders JF, Weller TH, Robbins FC. Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissue. Science 1949, 109: 85-9.
14. Enserik, M. Mission to MERS. Science 2014, 346: 1218-1220.
15. Gao F, Bailes E, Robertson DL, Chen Y, Rodenburg CM, Michael SF, Cummins LB, Arthur LO, Peeters M, Shaw GM, Sharp PM, Hahn BM. Origin of HIV-1 in the chimpanzee Pan troglodytes. Nature, 1999; 397: 436-441.
16. Gire SK, Goba A, Andersen KG, Sealfon RSG, Park DJ et al. (2014) Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 345(6202):1369-1372 doi: 10.1126/science.1259657.
17. Graham RL, Donaldson EF, Baric, RS. A decade after SARS: strategies for controlling emerging coronaviruses. Nature Reviews Microbiology 2013, 11: 836-848.
18. Josseran L, Paquet C, Zehgnoun A, Caillere N, Le Tertre A et al. (2006) Chikungunya disease outbreak, Reunion Island. Emerg Infect Dis 12 (12):1994-5.
19. Kobasa D, Takada A, Shinya K, Hatta M, Halfmann P, Theriault S, Suzuki H, Nishimura H, Mitamura K, Sugaya N, Usui T, Murata T, Maeda Y, Watanabe S, Suresh M, Suzuki T, Suzuki Y, Feldmann H, Kawaoka Y. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature, 2004, 431: 703-707.
20. Kupferschmidt K. MERS surges again, but pandemic jitters ease. Science 2015, 347: 1297-1297.
21. Lanciotti RS, Roehrig JT, Deubel V, et al. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science, 1999, 286: 2333-2337.
22. Li KS, Guan Y, Wang J, Smith GJD, Xu KM, Duan L, Rahardjo AP, Puthavathana P, Buranathai C, Nguyen TD, Estoepangestie ATS, Chalsingh A, Auewarakui P, Long HT, Hang NTH, Webby RJ, Poon LLM, Chen H, Shortridge KF, Yuen KY Webster RG, Peiris JSM. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature, 2004, 430: 209-213.
23. Li W, Shi Z, Yu M, Ren W, Smith C, Epstein JH, Wang H, Crameri G, Hu Z, Zhang H, Zhang J, McEachern J, Field H, Daszak P, Eaton BT, Zhang S, Wang LF. Bats are natural reservoirs of SARS-like coronavirus. Science 2005, 310: 676-678.
24. Messina JP, Brady OJ, Pigott DM, et al. The many projected futures of dengue. Nature Reviews Microbiology 2015, 13: 230-240.
25. Moore P, Chang Y. Kaposi's sarcoma (KS), KS-associated herpesvirus, and the criteria for causality in the age of molecular biology. Am Journal of Epidemiology, 1998, 147: 217-221.
26. Nichol ST, Spiropoulou CF, Morzunov S, Rollin PE, Ksiazek TG, Feldmann H, Sanchez A, Childs J, Zaki S, Peters CJ. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 1993, 262: 914-917.
27. Rasmussen AL, Okumura A, Ferris MT, Green R, Feldmann F, et al. Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance. Science 2014 346(6212):987-991. Doi 10.1126/science.1259595.
28. Reed W. Recent researches concerning etiology, propagation and prevention of yellow fever, by the United States Army Commission. Journal of Hygiene 1902, 2: 101-119.
29. Rouvinski A, Guardado-Calvo P, Barba-Spaeth G, et al. Recognition determinants of broadly neutralizing human antibodies against dengue viruses. Nature 2015, 520: 109-113.
30. Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. (2007) A single mutation in Chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog 3(12):e201. Doi:10.1371/journal.ppat.0030201.
31. Tumpey TM, Basler CF, Aguilar PV, Zeng H, Solorzano A, Swayne DE, Cox NJ, Katz JM, Taubenberger JK, Palese P, Garcia-Sastre A. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 2005, 310: 77-80.
32. Webster RG, Kawaoka Y, Bean WJJ. Molecular changes in A/chicken/Pennsylvania/83(H5N2) influenza virus associated with acquisition of virulence. Virology 1986;149:165-173. http://www.washingtonpost.com/sf/national/2014/10/04/how-ebola-sped-out-of-control/.
33. Butler D. Models overestimate Ebola cases. Nature 2014, 515: 18.
34. Cohen J. Breakdown of the year: Ebola. Science 2014, 346 1450-1451.
35. Dobson A. mathematical models for emerging disease. Science 2014, 346: 1294-1295.
36. Epstein JM, et al. Mobilizing Ebola survivors to curb the epidemic. Nature 2014 516: 323-325.
37. Feldmann H, Geisbert TW. Ebola hemorrhagic fever. Lancet 2011, 377: 849-862.
38. Gire SK, Goba A, Andersen KG, Sealfon RSG, Park DJ et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 2014, 345(6202):1369-1372 doi: 10.1126/science.1259657.
39. Kortepeter MG, Bausch DG, Bray M. Basic clinical and laboratory features of filoviral hemorrhagic fever. Journal of Infectious Diseases 2011, 204: S810-S816.
40. Marzi A, Feldmann H. Ebola virus vaccines: an overview of current approaches. Expert Review of Vaccines 2014, 13: 521-531.
41. Meltzer MI, Santibanez S, Knust B, Petersen BW, Ervin ED, Nichol ST, Damon IK, Washington ML. Estimating the Future Number of Cases in the Ebola Epidemic - Liberia and Sierra Leone, 2014-2015. Morbidity and mortality weekly report. 2014; 63: 1-14.
42. Mire CE, Matassov D, Geisbert JB, et al. Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus. Nature 2015, doi:10.1038/nature14428, Published online, 08 April 2015.
43. Paessler S, Walker DH. Pathogenesis of the viral hemorrhagic fevers. Annual Review of Pathology 2013, 8: 411-440.
44. Product: ReEBOV™ Antigen rapid test kit. http://www.who.int/medicines/ebola-treatment/1st_antigen_RT_Ebola/en/, 2015.
45. Rasmussen AL, Okumura A, Ferris MT, Green R, Feldmann F, et al. Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance. Science 2014, 346(6212):987-991. Doi 10.1126/science.1259595.
46. Vogel G. A reassuring snapshot of Ebola. Science 2015, 347: 1407.
47. WHO Ebola Response Team. Ebola virus disease in West Africa-The first 9 months of the epidemic and forward projections. N Engl J Med 2014; 371: 1481-1495.
48. WHO: EBOLA SITUATION REPORT, 29 April, 2015.
49. Etienne, L., Hahn, B.H., Sharp, P.M., Matsen, F.A., and Emerman, M. Gene loss and adaptation to hominids underlie the ancient origin of HIV-1. Cell Host Microbe 2013, 14: 85-92.
50. Hahn BH, Shaw GM, De Cock KM, Sharp PM AIDS as a zoonosis: scientific and public health implications. Science 2000, 287: 607-614.
51. Kluge, S.F., Mack, K., Iyer, S.S., Heigele, A., Learn, G.H., Usmani, S.M., Sauter, D., Joas, S., Hotter, D., Pujol, F.M., Bibollet-Ruche, F., Plenderleith, L., Peeters, M., Sharp, P.M., Fackler, O.T., Hahn, B.H. and Kirchhoff, F. Nef proteins of epidemic HIV-1 group O strains antagonize human tetherin. Cell Host Microbe, 2014, 16: 1-12.
52. Letko, M., Silvestri, G., Hahn, B.H., Bibollet-Ruche, F., Gokcumen, O., Simon, V. and Ooms, M. Vif proteins from diverse primate lentiviral lineages use the same binding site in APOBEC3G. J. Virol., 87:11861-11871, 2013. PMCID: PMC3807359.
53. Pepin J. The origins of AIDS. Cambridge University Press, Cambridge, UK, 2011.
54. Sharp, P.M. and Hahn, B.H. Origins of HIV and the AIDS pandemic. Cold Spring Harb. Perspect. Biol., 1: a006841, 2011, 1-22.